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Abstract 
Objectives: There have been several systematic reviews(SRs) on whether periodontal treatment for an individual 
with both periodontal disease and diabetes can improve diabetes outcomes. The purpose of this investigation was 
to conduct a systematic review (SR) of previous meta-analyses, and to assess the methodological quality of the SRs 
examining the effects of periodontal treatment and diabetes. (PROSPERO Registration # CRD 42015023470).
Study Design: We searched five electronic databases and identified previous meta-analyses of randomized control-
led trials published through July 2015. In cases where the meta-analysis did not meet our criteria, the meta-analy-
ses were recalculated. General characteristics of each included trial were abstracted, analyzed, and compared. The 
mean difference, 95% confidence intervals (CIs) and the I2 statistic were abstracted or recalculated. The Assess-
ment of Multiple Systematic Reviews Instrument (AMSTAR) was used to assess methodological quality. 
Results: Of the 475 citations screened, nine systematic reviews were included. In total, 13 meta-analyses included 
in nine SRs were examined. In comparability analyses, meta-analyses in four SRs did not meet our criteria, and 
were recalcuated. Of these 13 meta-analyses, 10 suggested significant effects of periodontal treatment on HbA1c 
improvement. Mean differences found in the 13 meta-analyses ranged from -0.93 to 0.13. AMSTAR assessment 
revealed six SRs with moderate and three with high overall quality.
Conclusions: We can conclude that there is a significant effect of periodontal treatment on improvement of HbA1c 
in diabetes patients, although the effect size is extremely small. In addition to the small effect size, not all SRs 
could be considered of high quality.
Key words: Periodontal treatment, diabetes, HbA1c, systematic review, systematic review  of systematic reviews, 
evidence-based medicine, AMSTAR.
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Introduction
Periodontal disease is one of the most prevalent chronic 
infections in adults worldwide. Many researchers have 
explored the association between periodontal diseases 
and diabetes over the years. Studies have shown that di-
abetic patients have a 2-3-fold higher risk of developing 
severe periodontitis and progressive periodontal disease 
(1). There has been much emphasis on the two-way rela-
tionship between periodontal disease and diabetes. Dia-
betes has many adverse effects on periodontal tissue, 
and conversely, periodontitis may further aggravate the 
diabetic condition. One of major questions in this two-
way relationship is whether periodontal treatment in an 
individual with both periodontal disease and diabetes 
can improve diabetes outcomes. 
Although clinical trials are a basis for good evidence, 
there is not always time to search for, read, and evalu-
ate many primary studies. It is much easier to find and 
read a summary or review of the evidence. Systematic 
reviews (SRs) aim to assimilate high-quality evidence 
in an area of interest in a systematic, transparent, and 
unbiased manner, leading to a qualitative or quantita-
tive synthesis. Multiple SRs may have been conducted 
on clinical questions that interest many clinicians. As 
the number of SRs begins to grow, one is likely to find 
different SRs on the same topic, conducted with differ-
ent aims and methodologies, and sometimes leading to 
conflicting results. Thus, critical reading and evaluation 
are necessary not only in assessing clinical trials but 
also in assessing SRs. Consequently, there is a need for 
efforts to provide an overview and comparison of exist-
ing SRs in a single paper.
 We aimed to systematically review existing SRs and to 
summarize the evidence relating to the effects of peri-
odontal treatment on diabetes outcomes. Thus, the aims 
of the present study were
• To provide an overview of the reported effects of peri-
odontal treatment on diabetes outcomes and to rate the 
evidence on which these effects are based; and
• To assess the methodological quality of the SRs exam-
ining the effects of periodontal treatment and diabetes.
Material and Methods
- Study Eligibility
This systematic review of previous systematic reviews 
of meta-analyses is registered in the PROSPERO trial 
registry (CRD 42015023470). Given that no guidelines 
currently exist for conducting SRs of previous SRs, the 
general guidelines of the Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis (PRISMA) 
Statement, where applicable, were followed (2). Follow-
ing Smith et al.’s approach for conducting a SR of SRs 
in healthcare interventions, the participants, interven-
tions, comparisons, outcomes, and study design (PI-
COS) structure is recommended (3). Thus, the scope of 
our topic can be rewritten according to the PICO struc-
ture as follows:
P: Patients with type 1 or type 2 diabetes diagnosed 
with periodontitis, regardless of the classification. 
I: Periodontal treatment with or without adjunctive use 
of local drug delivery and systemic antibiotics.
C: Control group with no periodontal treatment or de-
layed treatment.
O: Changes in glycated hemoglobin (HbA1c).
 Inclusion criteria for this study were: previous system-
atic reviews of meta-analyses of clinical trials; partici-
pants 16 years of age and older with type 1 or type 2 
diabetes and periodontitis; interventions consisting of 
periodontal treatment with or without adjunctive use 
of local drug delivery and systemic antibiotics; control 
group with no periodontal treatment or delayed treat-
ment; study duration more than 3 months; and  report-
ing data about glycated hemoglobin (HbA1c).
Studies that did not meet all of the criteria were ex-
cluded. Ineligible studies were excluded based on one 
or more of the following: inappropriate populations (for 
example, children); inappropriate interventions (for ex-
ample, periodontal treatment less than 3 months); inap-
propriate comparisons (for example, comparison among 
different kind of periodontal treatment); inappropriate 
outcomes (for example, serum levels of interleukin or 
CRP); and inappropriate study types (for example, sys-
tematic review without meta-analysis).
- Search Strategy
Five databases were searched: MEDLINE (PubMed) 
(1966 to July 25, 2015); Web of Science (1955 to July 25, 
2014); Cochrane Database of Systematic Reviews (1996 
to July 25, 2015); Trip Database (to July 25, 2015); and 
Centre for Reviews and Dissemination Database (1960 
to July 25, 2014). We combined search terms and limited 
the search to humans and the English language. While 
the specific search strategies varied depending on the 
database searched, key terms or forms of key terms 
included diabetes, periodontal, systematic review and 
meta-analysis, using identical search criteria and terms: 
((periodontal disease) OR (periodont*[Text Word]) 
OR (periodontitis) AND (diabetes[Text Word]) OR 
(diabet*[Text Word]) OR (diabetic*[Title]) OR (diabetic 
patient*[Text Word]) OR (diabetes patient[Text Word]) 
OR (non-insulin-dependent diabetes) OR (niddm[Text 
Word]) OR (insulin dependent diabetes[Text Word]) 
OR (iddm[Text Word]) OR (type 1 diabetes) OR (t1 
dm) OR (type 2 diabetes) OR (t2 dm) AND (therapy) 
OR (treatment) OR (intervention)) AND systematic[sb] 
AND (english[Language]).  In addition, manual search-
es of the references from selected original research and 
review articles were also conducted.
- Comparability Analysis of Meta-analyses
There were various forms and patterns of meta-analyses 
in the included SRs. Because it is difficult to compare 
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results of meta-analyses described in various formats, it 
was necessary to unify the forms of the meta-analyses. 
Consequently, prior to data synthesis, the following four 
criteria were verified. In cases where the meta-analysis 
did not meet any of these four criteria, the meta-analy-
ses were recalculated.
• Are outcome indices presented as comparisons of 
%A1C improvement between the intervention and the 
control groups?
• Are there any obvious transcription errors between 
indices presented in the meta-analysis and original tri-
als?
• Is a random effects model used for combining data in 
the meta-analysis?
• Are results of a heterogeneity analysis presented?
Meta-analyses that failed any of these items needed to be 
recalculated. In these cases, the Revman5.3 software was 
used to generate meta-analyses from indices presented in 
reports of the original trials. Data from the regenerated 
meta-analyses were then used in our analysis.
- Data Analysis
 General characteristics of each included trial were ab-
stracted, analyzed, and compared. The mean difference 
and 95% confidence intervals (CIs) were abstracted or 
recalculated. The I2 statistic, a measure of heterogene-
ity, was also abstracted if it was provided in the meta-
analysis. If I2 was not reported, it was calculated, if suf-
ficient data were available.
Methodological Quality assessment: AMSTAR check-
list
The proliferation of systematic reviews in the clinical 
field renders it challenging for clinicians to use reviews 
in making clinical decisions because it is difficult to dis-
tinguish good from poor-quality reviews; the AMSTAR 
checklist is an easy-to-use tool purposely developed to 
address this need (4). Two reviewers (SI, EK) independ-
ently rated study quality using the 11-item AMSTAR 
checklist; where differences were noted, these were 
resolved by discussion between the two reviewers, and 
where agreement could not be reached, a third reviewer 
(DS) resolved the issue. Finally, the score for each item 
on the checklist was analyzed individually (AMSTAR 
matrix analyzed by columns) to identify which items 
future research should focus on to improve the quality 
of reviews.
Results 
- Study Selection
In total, 475 references were initially identified. After 
duplicate were removed, 375 articles remained. Of the 
375 screened, 19 articles were selected for final eligi-
bility assessment. Of the 19 articles, nine met all study 
eligibility criteria (5-13). Figure 1 illustrates the search 
process.
Characteristics of Included SRs
First, comparability analyses of the meta-analyses were 
Fig. 1. Flow diagram for the selection of SRs.
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conducted. The meta-analyses in four SRs did not meet 
our criteria (Table 1). Obvious transcription errors be-
tween indices presented in the meta-analysis or original 
trials were confirmed in three of four SRs. In Simpson’s 
Cochrane review, the index was presented as a compari-
son of HbA1c measured after following up between test 
and control (12), although in others, it was presented as 
comparison of the two groups in in HbA1c improve-
ment. We recognized the need to include these four me-
ta-analyses, and we present our newly calculated meta-
analyses. In the meta-analysis of Simpson’s Cochrane 
review article, recalculation was done the improvement 
in HbA1c in both groups and a random effects model. 
The reanalyzed meta-analysis revealed that the newly 
calculated 95% CI range was wider than that reported 
in the original SR and that there was no statistically sig-
nificant difference between the groups. Thus, this result 
was inconsistent with that reported in the original meta-
analysis.
General characteristics of the nine SRs included are 
described in table 2. Although minor differences ex-
isted in the details of the periodontal treatment, no fatal 
inconsistency relative to the PICO framework was ob-
served in the nine SRs.
Two of the nine SRs included not only randomized con-
trolled trials but also clinical controlled trials (6,13). 
The last search day was in 2012 in four of the nine SRs 
(6,8,10,11). There were several SRs that conducted sub-
group analyses focused on sample size (5), follow-up 
period (6,7), risk of bias (RoB) (8), and use of antibiotics 
(12).
A quality assessment of each included clinical trial was 
made for all nine SRs using some type of risk-of-bias 
tool. For example, sequence generation, allocation con-
cealment, blinding, incomplete outcome data, and se-
lective outcome reporting were assessed. An analysis 
of publication bias was conducted in five of nine SRs 
(5,7,9-11), and an analysis of heterogeneity was conduct-
ed in all nine SRs (Table 2).
In total 25, clinical trials were included in the nine SRs. 
Of the 25 trials, 12 were included in more than two SRs 
(14-25). Only one trial was included in all nine SRs (14).
Efficacy of periodontal treatment
There were three categories of follow-up time among 
the included meta-analyses: 3-month duration, 6-month 
duration, and all durations combined. In total, 13 me-
ta-analyses were reported in the nine SRs. Of the 13 
meta-analyses, 10 suggested significant improvement in 
HbA1c by periodontal treatment. The values of mean 
differences suggested in the 13 meta-analyses ranged 
from -0.93 to 0.13 (Table 3). Results of the comparison 
of the 13 meta-analyses indicated a significant effect of 
periodontal treatment on improved HbA1c in diabetes 
patients, although the effect size was extremely small. 
Nevertheless, even this small improvement in HbA1c  
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must be interpreted with care due to high heterogeneity, 
as evidenced by I2 values over 40% confirmed in nine 
of the 13 meta-analyses.
In a comparison between meta-analyses with a 3-month 
and those with a 6-month follow-up, no correlation be-
tween observation period and effect size was seen. In a 
sub-group analysis, Quan Li et al. stratified the analysis 
by sample size (5). Their analysis suggested that sub-
group analysis of small RCTs (n <80) showed a greater 
effect size and smaller heterogeneity than did large 
sample size trials.
- AMSTAR Assessment
Assessment of the methodological quality of the select-
ed reviews showed that no review answered all 11 ques-
tions of the AMSTAR tool. Overall, the AMSTAR tool 
revealed six studies with moderate (four to seven) and 
three with high (eight to eleven) methodological quality 
(Table 4). Reviews that stood out from the rest were the 
SRs published by Sgolastra et al. (11) and by Simpson 
et al. (12) These SRs reported both the included and the 
excluded studies in the publication (item 5). All of the 
included SRs had a focused question (item 1) and pro-
vided characteristics of the included studies in the form 
of tables (item 6). None of the nine SRs reported con-
flicts of interest for not only the SRs themselves but also 
each trial included in the SRs.
Discussion 
Our SR of SRs reviewed overall evidence supporting 
the effect of periodontal treatment on diabetes out-
comes from the viewpoints of effect size and rigor of 
the evidence. We can conclude that there is a signifi-
cant effect of periodontal treatment on improvement of 
HbA1c in diabetes patients, although the effect size is 
extremely small. In addition to this small effect size, the 
supporting evidence cannot be regarded as high quality. 
These facts regarding periodontitis and diabetes should 
be well known to healthcare workers and patients.
One of the desirable properties of high-quality system-
atic review is rigorousness in selecting, synthesizing, 
and assessing the quality of the evidence. In addition 
to these characteristics, regular updating is also essen-
tial for a good-quality systematic review. The Grades 
of Recommendation, Assessment, Development, and 
Evaluation (GRADE) approach is among the most ac-
cepted approaches of today for appraising the evidence 
and generating recommendations in the fields of gen-
erating systematic reviews and clinical practice guide-
lines (26). The GRADE approach has been adopted by 
countless societies all over the world and has been used 
in many healthcare fields. In this SR of SRs, GRADE 
was used only for Simpson’s Cochrane review to ap-
praise the quality of evidence among the nine included 
SRs (12). This Cochrane review can be judged as a high-
quality review based on an AMSTAR assessment.S
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In this SR of SRs, nine SRs focused on almost the same 
clinical questions were included. It is remarkable that 
only one trial was included in the trials lists of all nine 
SRs (14). One 6-month, single-masked, multicenter, ran-
domized clinical trial (257 participants in each group) 
(23) was included in two SRs published in 2014 (7) and 
2015 (5). The results of this large RCT showed that glyc-
emic control in patients with type 2 diabetes and moder-
ate to advanced chronic periodontitis was not able to be 
improved by nonsurgical periodontal treatment. Though 
this result conflict with ones obtained from most of all 
other trials, statistical weight of this trial tends to be 
high due to its large sample size. As many authorities in 
periodontology suggested in the critical article, readers 
need to take into account that patients’ characteristics in 
this trial were different from those in other trials (27).
Nine SRs were published within a 5-year period, and 
three of the nine SRs were published in the same year, 
2012. None of the nine SRs has been updated. Whether 
more SRs focused on same topic are needed is argu-
able. Updating some specific rigorous and high- quality 
SRs regularly seems better than performing new SRs 
conducted using different methodologies and differing 
in quality.
In this SR of SRs, the qualities of each SR were as-
sessed using the AMSTAR scoring system. AMSTAR 
scores for each study were not low as a whole, although 
some SRs only achieved a score of 4. However, it must 
be recalled that AMSTAR is only a format evaluation 
system. In the present SR of SRs, obvious transcription 
errors between indices presented in the meta-analysis 
and original trials were found in some SRs. Regardless 
of how high the scores for these SRs become, they can-
not be regarded as high-quality SRs. Furthermore, in 
AMSTAR, there is no item related to updates. It is im-
portant to take these things into account when assessing 
the quality of SRs using AMSTAR.
The spread of clinical practice guidelines and SRs have 
changed the ways healthcare workers and patients deal 
with evidence. It is important to continue to discuss how 
best to generate, access, and assess evidence.
Conclusions 
There is a significant effect of periodontal treatment on 
improvement of HbA1c in diabetes patients, although 
the effect size is extremely small. In addition to this 
small effect size, the supporting evidence cannot be re-
garded as high quality.
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